SpringWorks Therapeutics Inc (SWTX)
41.20
-1.75
(-4.07%)
USD |
NASDAQ |
May 10, 13:34
SpringWorks Therapeutics Profit Margin (Quarterly): -416.0% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -416.0% |
| December 31, 2023 | -1.73K% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 32.21% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.73K%
Minimum
Dec 2023
32.21%
Maximum
Dec 2020
-705.1%
Average
-416.0%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | -- |
| Alnylam Pharmaceuticals Inc | -13.34% |
| Geron Corp | -18.22K% |
| Ionis Pharmaceuticals Inc | -119.5% |
| Madrigal Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.56% |
| Return on Assets | -57.73% |
| Return on Invested Capital | -66.56% |
| Gross Profit Margin (Quarterly) | 94.28% |
| Operating Margin (Quarterly) | -447.2% |
| Return on Net Operating Assets | -1.03K% |